Due to the regulatory role of HAT1 in the PVT1 expression, HAT1 can be considered one of the therapeutic targets for reducing the oncogenic effects of PVT1 on pancreatic cancer cells. The gene discussed is HAT1; the disease is familial pancreatic carcinoma.